Synapse Open Synapse
Biology

Publisher Correction: RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss

Nature Biological Sciences ·

npj Drug Discovery - Publisher Correction: RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss

Latest from Nature Biological Sciences